27578508|t|Evaluation of the VIDAS Anti-HCV Assay for Detection of Hepatitis C Virus Infection
27578508|a|Anti-hepatitis C virus antibody (anti-HCV) assays are recommended for screening HCV -infected persons. The VIDAS Anti-HCV Assay (bioMÃ©rieux, France), based on the enzyme-linked fluorescence test principle, was recently introduced in Korea. We evaluated the clinical performance of the VIDAS assay. One hundred HCV-positive and 1,002 HCV-negative blood samples confirmed by Architect anti-HCV (Abbott Laboratories, USA) and COBAS TaqMan HCV real-time PCR (Roche Diagnostics, USA) or the Procleix Ultrio Plus Assay (Gen-Probe Incorporated, USA) were obtained from the Human Serum Bank (HSB) and tested by VIDAS. In case of discrepant results, we conducted a recombinant immunoblot assay (RIBA). The agreement rates for known HCV-positive and HCV-negative samples between the VIDAS assay and the HSB testing were 100% (95% confidence interval [CI]: 96.4-100%) and 99.5% (95% CI: 98.8-99.8%), respectively. One of the five discrepant samples was positive for Core 2+ and NS3-2 2+ reactivity, two samples were negative, and the other two were indeterminate regarding NS4 2+ reactivity in RIBA. We observed a significant but weak positive correlation between the titers of VIDAS and Architect assays (r=0.315, P<0.001). The VIDAS anti-HCV assay, developed on the VIDAS automated immunoassay platform based on the ready-to-use, single-sample test concept may be useful in small-to-medium-sized laboratories. It showed good agreement with Architect anti-HCV and COBAS PCR assays and is therefore useful for detection of HCV infection. Weakly test-positive (ambiguous) samples require additional testing by another anti-HCV, RIBA, or HCV RNA assay.
27578508	0	10	Evaluation	T058	C0220825
27578508	18	38	VIDAS Anti-HCV Assay	T059	C0005507
27578508	43	52	Detection	T061	C1511790
27578508	56	83	Hepatitis C Virus Infection	T047	C4288963
27578508	84	115	Anti-hepatitis C virus antibody	T116,T129	C0166049
27578508	117	125	anti-HCV	T116,T129	C0166049
27578508	127	133	assays	T059	C0005507
27578508	154	163	screening	T058	C1710032
27578508	164	167	HCV	T005	C0220847
27578508	164	185	HCV -infected persons	T098	C0027361
27578508	191	211	VIDAS Anti-HCV Assay	T059	C0005507
27578508	225	231	France	T083	C0016674
27578508	247	278	enzyme-linked fluorescence test	T059	C0022885
27578508	279	288	principle	T078	C0178566
27578508	317	322	Korea	T083	C0022771
27578508	341	349	clinical	T080	C0205210
27578508	350	361	performance	T052	C1882330
27578508	369	380	VIDAS assay	T059	C0005507
27578508	394	406	HCV-positive	T034	C1112419
27578508	417	429	HCV-negative	T034	C1619717
27578508	430	443	blood samples	T031	C0178913
27578508	457	475	Architect anti-HCV	T059	C0005507
27578508	477	496	Abbott Laboratories	T093	C1552881
27578508	498	501	USA	T083	C0041703
27578508	507	537	COBAS TaqMan HCV real-time PCR	T063	C1709846
27578508	539	556	Roche Diagnostics	T092	C3828314
27578508	558	561	USA	T083	C0041703
27578508	570	596	Procleix Ultrio Plus Assay	T059	C0005507
27578508	622	625	USA	T083	C0041703
27578508	650	666	Human Serum Bank	T093	C0597886
27578508	668	671	HSB	T093	C0597886
27578508	687	692	VIDAS	T059	C1553144
27578508	705	723	discrepant results	T033	C1290905
27578508	740	768	recombinant immunoblot assay	T059	C2987205
27578508	770	774	RIBA	T059	C2987205
27578508	781	796	agreement rates	T081	C1521828
27578508	807	819	HCV-positive	T034	C1112419
27578508	824	836	HCV-negative	T034	C1619717
27578508	837	844	samples	T031	C0178913
27578508	857	868	VIDAS assay	T059	C0005507
27578508	877	880	HSB	T093	C0597886
27578508	904	923	confidence interval	T081	C0009667
27578508	925	927	CI	T081	C0009667
27578508	956	958	CI	T081	C0009667
27578508	1003	1013	discrepant	T033	C1290905
27578508	1014	1021	samples	T031	C0178913
27578508	1026	1034	positive	T033	C1446409
27578508	1039	1046	Core 2+	T129	C0019166
27578508	1051	1059	NS3-2 2+	T129	C0021054
27578508	1076	1083	samples	T031	C0178913
27578508	1089	1097	negative	T033	C0205160
27578508	1146	1152	NS4 2+	T129	C0021054
27578508	1167	1171	RIBA	T059	C2987205
27578508	1217	1228	correlation	T080	C1707520
27578508	1241	1247	titers	T081	C0475208
27578508	1251	1256	VIDAS	T059	C1553144
27578508	1261	1277	Architect assays	T059	C0005507
27578508	1302	1322	VIDAS anti-HCV assay	T059	C0005507
27578508	1341	1346	VIDAS	T059	C1553144
27578508	1347	1377	automated immunoassay platform	T059	C0020980
27578508	1471	1483	laboratories	T073,T093	C0022877
27578508	1515	1533	Architect anti-HCV	T059	C0005507
27578508	1538	1554	COBAS PCR assays	T063	C1709846
27578508	1596	1609	HCV infection	T047	C4288963
27578508	1611	1643	Weakly test-positive (ambiguous)	T034	C0456984
27578508	1644	1651	samples	T031	C0178913
27578508	1690	1698	anti-HCV	T116,T129	C0166049
27578508	1700	1704	RIBA	T059	C2987205
27578508	1709	1722	HCV RNA assay	T059	C1272251